DI NOTO, Laura
 Distribuzione geografica
Continente #
EU - Europa 128.026
NA - Nord America 694
AS - Asia 108
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 1
SA - Sud America 1
Totale 128.836
Nazione #
IE - Irlanda 127.597
US - Stati Uniti d'America 694
IT - Italia 111
FI - Finlandia 100
UA - Ucraina 87
CN - Cina 84
DE - Germania 40
GB - Regno Unito 22
BE - Belgio 18
RO - Romania 15
SG - Singapore 13
SE - Svezia 11
RU - Federazione Russa 10
EU - Europa 6
FR - Francia 6
IN - India 6
ES - Italia 4
CH - Svizzera 2
NL - Olanda 2
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
TR - Turchia 1
Totale 128.836
Città #
Dublin 127.597
Ann Arbor 89
Ashburn 84
Chandler 58
Fairfield 55
Jacksonville 48
Des Moines 45
Woodbridge 39
Houston 30
Wilmington 30
Palermo 28
Cambridge 20
Brussels 18
Seattle 18
Medford 17
Nanjing 16
Princeton 13
Boardman 10
Shenyang 10
Tulsa 10
Altamura 9
Beijing 8
Nanchang 8
New York 8
Jinan 7
Lawrence 7
Changsha 6
Singapore 6
Washington 6
Dearborn 5
Kumar 5
Milan 5
Zhengzhou 5
Albacete 4
Ludwigshafen am Rhein 4
Rome 4
San Diego 4
Verona 4
Falls Church 3
Jiaxing 3
Norwalk 3
Santa Clara 3
Tianjin 3
Auburn Hills 2
Changzhou 2
Genoa 2
Hangzhou 2
Hebei 2
Helsinki 2
San Mateo 2
Torino 2
Abidjan 1
Dallas 1
Durham 1
Guangzhou 1
Haikou 1
Hanover 1
Izmir 1
Kilburn 1
Lanzhou 1
Lecce 1
Levanto 1
Los Angeles 1
Moscow 1
Nanning 1
Ningbo 1
Orange 1
San Paolo di Civitate 1
Santiago 1
Seongnam 1
Shaoxing 1
Stuttgart 1
Taiyuan 1
Taizhou 1
Tehran 1
Terni 1
Xi'an 1
Zhangzhou 1
Totale 128.398
Nome #
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella. 127.713
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 171
“Cytokine gene polymorphisms and breast cancer susceptibility” 154
“High efficacy of the CHOP + Rituximab association in a case of primary rectal non Hodgkin lymphoma (NHL)” 120
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients 110
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)” 99
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 95
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 92
“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)” 86
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 78
“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)” 71
"Weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: results of a phase II study” 56
Totale 128.845
Categoria #
all - tutte 131.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020230 0 0 16 11 26 31 28 16 31 13 37 21
2020/2021155 2 19 3 18 18 1 16 9 27 12 14 16
2021/2022120 6 28 2 2 5 9 6 2 20 12 3 25
2022/2023224 34 28 3 17 24 31 39 14 20 0 5 9
2023/2024132 13 11 3 18 16 18 10 27 1 2 2 11
2024/202517 4 11 2 0 0 0 0 0 0 0 0 0
Totale 128.845